Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006-2016
Abstract Background Germline pathogenic variants in BRCA1/2 have been established in hereditary breast and ovarian cancer (HBOC) syndrome and result in significantly elevated lifetime risk of ovarian cancer. Risk reduction interventions are presently the only effective means of improving survival an...
Saved in:
Main Authors: | Lauren Adolph (Author), Ashley Warias (Author), Jocelyn Stairs (Author), Kelly Collins-McNeil (Author), Lynette Penney (Author), Katharina Kieser (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hereditary Leiomyomatosis and Renal Cell Cancer
by: Anders Würgler Hansen, et al.
Published: (2020) -
Hereditary determinants of gynecological cancer and recommendations
by: Jesus Paula Carvalho, et al.
Published: (2021) -
Gynecologic and breast cancers with hereditary cancer predisposition syndromes
by: Courtney F. Connelly, et al.
Published: (2024) -
Hereditary breast cancer and ovarian cancer: clinical course and treatment
by: V. V. Semiglazov, et al.
Published: (2021) -
16 Fertility outcomes in women with hereditary cancer syndromes
by: Elizabeth Connelly, et al.
Published: (2023)